Luad - OmicsDI

Show results for

Unknown (4034)
Genomics (626)
Transcriptomics (484)
Proteomics (94)
Other (24)
Methylation profiling (17)
Genomic (2)
Metabolomics (2)

Organisms

Homo sapiens (556)
Mus musculus (164)
Bombyx mori (40)
Onchocerca volvulus (40)
Klebsiella pneumoniae (40)
Musca domestica (40)
Brugia malayi (40)
Schizosaccharomyces pombe (40)
Streptomyces coelicolor A3(2) (40)
Sus scrofa (40)
Human immunodeficiency virus 1 (40)
Oryza sativa Indica Group (40)
Sinorhizobium meliloti BL225C (40)
Vitis (40)
Sus scrofa domesticus (40)
Ostreococcus tauri (40)
Saccharomyces cerevisiae (40)
Synechocystis sp. PCC 6803 (40)
Olavius algarvensis Gamma 1 endosymbiont (40)
Vitis vinifera (40)
Saccharopolyspora erythraea (40)
Staphylococcus aureus (40)
Rattus norvegicus (40)
Rattus rattus (40)
Pseudomonas aeruginosa (40)
Olavius algarvensis Delta 4 endosymbiont (40)
Rattus norvegicus (1)
synthetic construct (1)
Bos taurus (1)
Escherichia coli (1)

Organisms

Homo sapiens (278)
Mus musculus (105)

Repository

ENA (469)
geo (358)
biostudies-arrayexpress (245)
EGA (75)
pride (40)
MassIVE (26)
iProX (21)
jPOST (6)
EVA (3)
dbGaP (2)
MetaboLights (2)
NODE (1)
PanoramaPublic (1)

Tissue

Lung (21)
Epithelial cell (10)
Cell culture (8)
Blood plasma (6)
Lung adenocarcinoma cell (2)
Liver (2)
Pancreatic cancer cell line (1)
Pancreas exocrine glandular cell (1)
Pancreatic ductal carcinoma cell (1)
Epithelial cell of lung (1)
Melanocyte (1)
Extracellular vesicle (1)
Skin (1)
Lymph node (1)
Heart (1)
Brain (1)
Spleen (1)
Permanent cell line cell (1)
Kidney (1)

Disease

Lung adenocarcinoma (12)
Non-small cell lung carcinoma (3)
Lung cancer (3)
Adenocarcinoma (2)
Lung non-squamous non-small cell carcinoma (2)
Melanoma (2)
Lung Cancer (1)
Malignant pleural mesothelioma (1)
Malignant mesothelioma (1)
Carcinoma (1)
Lung carcinoma (1)
Pancreatic ductal adenocarcinoma (1)

Technology Type

Mass Spectrometry (40)
Shotgun proteomics (16)
Data-dependent acquisition (12)
Bottom-up proteomics (9)
Data-independent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Illumina HiSeq 2000 (2)
SRM/MRM (2)
Illumina HiSeq 2500, Illumina HiSeq 2000 (ILLUMINA), Illumina HiSeq 2000, Illumina (1)
Illumina HiSeq 4000, Illumina HiSeq 2500, ILLUMINA (1)
HiSeq X Ten, ILLUMINA (1)
HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2000 (1)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Mass spectrometry (1)
Mass spectrometry assay (1)
Olink affinity proteomics (1)
Affinity proteomics (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Fusion Lumos (11)
Illumina NovaSeq 6000 (7)
Illumina HiSeq 4000 (6)
NextSeq 500 (6)
Illumina HiSeq 2500 (3)
LTQ Orbitrap Velos (3)
Q Exactive (3)
General usage Laborartory equipment (2)
Lab Centrifuge (2)
HiSeq X Ten (2)
Orbitrap Exploris 480 (2)
Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq X (1)
Ion Torrent PGM (1)
Ion Torrent Proton (1)
NextSeq 550 (1)
Bio-Rad CFX96 (1)
- (1)
EVOQ Elite (1)
TimsTOF HT (1)
QE-HF (1)
MaXis II (1)
Orbitrap Astral (1)
Q Exactive HF-X (1)
Orbitrap Exploris 240 (1)
LTQ Orbitrap (1)
Q Exactive Plus (1)
Q Exactive HF (1)

Publication Date

2026 (96)
2025 (94)
2024 (77)
2023 (55)
2022 (42)
2020 (36)
2014 (36)
2015 (32)
2021 (30)
2012 (26)
2013 (25)
2019 (24)
2016 (24)
2011 (22)
2010 (17)
2018 (15)
2009 (15)
2008 (10)
2017 (4)
2005 (3)
2007 (2)
2006 (1)

Metabolite Name

Cystathione (2)
N-Acetyl-D-Glucosamine (2)
Melibiose (2)
Sphingosine (2)
Kynurenine (2)
Phytosphingosine (2)
L-Tryptophan (2)
Adenosine (2)
Adenine (2)
D-Glucose (2)
L-Histidine (2)
L-Lysine (2)
DG(PGF1alpha/0:0/15:0) (1)
PE(PGF1alpha/22:4(7Z,10Z,13Z,16Z)) (1)
Methyl 5-(methoxymethyl)-4,5-dimethyl-2-oxofuran-3-carboxylate (1)
Nx2 toxin (1)
2-(3-hexyl-4-methyl-2,5-dioxopyrrol-1-yl)-3-hydroxybutanoic acid (1)
7-methyl-2-(4-pyrimidin-2-ylpiperazin-1-yl)-7,8-dihydro-6H-quinazolin-5-one (1)
(2R)-2-Amino-4-(amino-butyl-oxo-lambda6-sulfanylidene)butanoic acid (1)
2-((3-ethoxy-3-oxopropanoyl)oxy)-n,n,n-trimethylethan-1-aminium (1)
N-phenyl-N'-(2-{[5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetyl)urea (1)
1,2,2,6,6-pentamethylpiperidin-4-ol (1)
Met-Gly-Tyr (1)
7-hydroxychroman-2-one (1)
N-(Cyclohexylmethyl)-3-{[5-(phenoxymethyl)-1,2-oxazol-3-yl]methyl}-3-oxetanamine (1)
2-Methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo(1,5-a)pyridine (1)
Ile-Asn-Ser (1)
4-formylaminoantipyrine (1)
2-(2-hydroxy-3-methylsulfanylpropyl)-1H-pyridazine-3,6-dione (1)
Asn-Gly-Tyr (1)

First Public Date

2025 (106)
2026 (88)
2024 (82)
2023 (49)
2022 (39)
2021 (33)
2020 (31)
2019 (25)
2018 (8)
2017 (4)
2016 (2)
2015 (2)

Study type

Transcription profiling by array (148)
RNA-seq of coding RNA (30)
Comparative genomic hybridization by array (15)
ChIP-seq (10)
Methylation profiling by array (8)
Transcription profiling by RT-PCR (4)
RNA-seq of non coding RNA (4)
Human - High-throughput sequencing (3)
Other (3)
DNA-seq (3)
ChIP-chip by array (2)
Exome sequencing (2)
RNA-seq of coding RNA from single cells (2)
Methylation profiling by high throughput sequencing (2)
RNA-seq of total RNA (2)
Unknown experiment type (1)
Human - Two-color microarray (1)
Human - Methylation microarray (1)
Cell line - One-color microarray (1)
Human - One-color microarray (1)
RNAi profiling by array (1)
Genotyping by array (1)

Release Date

2022 (878)
2025 (712)
2023 (625)
2024 (609)
2021 (552)
2020 (345)
2019 (134)
2026 (87)
2018 (68)
2014 (38)
2016 (37)
2015 (37)
2017 (33)
2013 (27)
2012 (26)
2011 (22)
2010 (17)
2009 (15)
2008 (10)
2005 (3)
2007 (2)
2006 (1)

Lab affiliation

1State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China 2Department of Biochemistry and Molecular Biology, School of Life Sciences, Peking University, Beijing, China, Peking University, Beijing 100871, China (2)
Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 (2)
Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan (2)
Department of Oncology Pathology, Karolinska Institute, Solna, Sweden (2)
Institute for Research in Immunology and Cancer, Department of Biochemistry, Department of Chemistry, Université de Montréal, Québec, Canada H3T 1J4 (2)
Department of Oncology-Pathology, Karolinska Institutet (1)
The Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), (1)
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China (1)
Clinical Proteomics Laboratory, Institute of Chemistry, UPD (1)
Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University (1)
Professor, Department of Molecular Genetics, University of Toronto, Canada Scientific Director, SPARC BioCentre, Hospital for Sick Children (Sickkids), Toronto, Canada (1)
The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China. (1)
1Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA (1)
Department of Clinical Pathology, First Affiliated Hospital of Jinan University, Guangzhou, China (1)
Proteomics Unit, CNIO (1)
MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, Guangzhou, China (1)
Department of Medical Genetics, University of British Columbia, Vancouver, Canada (1)
VIB-KU Leuven Center for Cancer Biology (1)
Faculty of Biology Technion-Israel institute of Technology (1)
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. (1)
Professor, Gerald Bronfman Department of Oncology, McGill University, Montréal, Quebec, H3G 1Y6, Canada (1)
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1)
Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory, Sweden (1)
State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China/College of Pharmacy, Jinan University, Guangzhou, 510632, China (1)
Genome Insistute of Singapore (GIS) (1)
Department of Clinical Sciences Division of Clinical Protein Science and Imganing (1)
Department of Biological Engineering, Massachusetts Institute of Technology (1)
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge MA, 02139, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA, 02139, USA; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge MA, 02139, USA (1)
Mass Spectrometry & Proteomics Core Facility (MSPCF) Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology (BIST) C/ Baldiri Reixac, 10-12 08028 Barcelona - Spain. (1)
Washington University in St. Louis (1)

Previous page
1 / 529
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 529
Next page

Sort by:

Relevance

Page size

RNA-seq of murine LUAD tumors on control diet or alpha-ketoglutarate diet for 16-weeks compared by sex

12-week old B6 Kras-LUAD mice were maintained on a control diet or alpha-ketoglutarate diet for 16-weeks before LUAD tumors were collected and used for bulk RNA-sequencing.

ORGANISM(S): Mus musculus

2026-09-01 | E-MTAB-15597 | biostudies-arrayexpress

RNAseq of combined LUAD and SCLC tumors to look at gene expression changes

For in-depth characterization of neuroendocrine transformation, we analyzed clinical specimens consisting of combined lung adenocarcinoma (LUAD)/small cell lung carcinoma (SCLC) histology exhibiting clear spatial separation. Microdissection was performed for RNA sequencing.

ORGANISM(S): Homo sapiens

2021-06-03 | E-MTAB-10399 | biostudies-arrayexpress

LUAD spatial transcriptomics

PRJNA1213055 | ENA

Circ101093 regulated proteins in Lung carcinoma (LUAD) cells.

Circ101093 was knocked down in A549 LUAD cell lines, and overexpressed in H1975 LUAD cell lines. Then, downregulated proteins in A549 cell lines and upregulated proteins in H1975 cell lines were analyzed.

ORGANISM(S): Homo sapiens (Human)

2022-05-20 | PXD025491 | Pride

Response of LUAD cells to LCS3

PRJNA738470 | ENA

TPX2-mediated autophagy maintains cancer stemness in LUAD

PRJNA1471262 | ENA

Epigenome analysis of normal and lung adenocarcinoma (LUAD) samples

PRJNA1150555 | ENA

LUAD tumor, normal adjacent and tumoroid bulk transcriptomics

PRJNA1213059 | ENA

Transcriptional profiling of p53 mutants in KP LUAD cells

PRJNA561864 | ENA

CPTAC LUAD Discovery Study

Proteogenomics of Lung Adenocarcinoma, Gillette et al., 2020 publication is here

Lung cancer is a leading cause of cancer death in the United States and in 2019 it is estimated that there will be over...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Mus Musculus (ncbitaxon:10090)

2021-02-01 | MSV000086793 | MassIVE

Previous page
1 / 529
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 529
Next page

Sort by:

Relevance

Page size

5283 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets